IL6 and infection: However, its safety and efficacy in this context have not yet been evaluated in clinical trials.276 Importantly, systemic blockade of IL-6 may also impair tissue repair and disrupt immune homeostasis maintained by classical IL-6 signaling, thereby potentially increasing the risk of infection.